The Effects of Alpha Stimulation on Induced Anxiety by Hill, Nolan Thomas
Abilene Christian University
Digital Commons @ ACU
Electronic Theses and Dissertations Graduate School
Fall 12-22-2015
The Effects of Alpha Stimulation on Induced
Anxiety
Nolan Hill
Abilene Christian University, nxh13a@acu.edu
Follow this and additional works at: http://digitalcommons.acu.edu/etd
Part of the Alternative and Complementary Medicine Commons, Behavior and Behavior
Mechanisms Commons, Cognitive Behavioral Therapy Commons, Mental Disorders Commons,
Other Mental and Social Health Commons, Psychiatric and Mental Health Commons,
Psychoanalysis and Psychotherapy Commons, and the Psychological Phenomena and Processes
Commons
This Thesis is brought to you for free and open access by the Graduate School at Digital Commons @ ACU. It has been accepted for inclusion in
Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ ACU. For more information, please contact dc@acu.edu.
Recommended Citation
Hill, Nolan, "The Effects of Alpha Stimulation on Induced Anxiety" (2015). Digital Commons @ ACU, Electronic Theses and
Dissertations. Paper 6.
ABSTRACT
Anxiety is defined as an emotional and physical reaction that prepares us to 
confront a feared stimulus.  Among the many measureable changes induced by anxiety 
are changes in facial electromyography (EMG), heart rate (HR), and sweat gland activity 
(EDG). At a pathological level anxiety interferes with cognitive processes. Currently, 
when anxiety crosses into the pathological level, it is treated with a variety of therapies 
that share in their use of periods of exposure to anxiety-inducing stimuli. Several devices 
have been developed to alter brain activity by transcranial electrical stimulation (TCES). 
One such device, Alpha-Stim
®
, has been shown to reduce anxiety in clinical samples. 
This suggests that the device might be useful in therapeutic exposure sessions, though no 
research to date has examined its use in such settings. In a double-blind, placebo 
controlled study participants were exposed to stimuli derived from the International 
Affective Picture System (IAPS) database that were chosen for their ability to elicit 
anxiety. A repeated measures analysis of variance was performed on recorded 
physiological data (EDG, HR, EMG) and subjective experience of anxiety as measured 
with Subjective Units of Distress Scale. Analysis of subjective units of distress scores 
showed that repeated exposure to anxiety eliciting pictures produced decreasing levels of 
distress over time (F (1,13) = 5.831, p = .031). EDG analysis revealed no statistically 
significant results. HR analysis revealed that TCES produced lower heart rates 
throughout the exposure (main effect of treatment; F (1,12) = 120.907 p < .001), and a 
trend toward increased heart rate during the exposure (treatment by time interaction; F 
(1,12) = 3.514, p = .085). Frontalis EMG analysis revealed a trend for the treatment 
groups to differ in their experience of negative emotional valence over the course of the 
exposure (F (1,12) = 3.209, p = .098). 
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CHAPTER I 
INTRODUCTION
Exposure remains the most efficacious treatment for anxiety disorders. Yet being 
the most effective therapy does not mean it is appropriate for every individual. There are 
many reasons for this. Most importantly, some prospective patients may be unable to 
tolerate the distress provoked by exposure procedures. For these individuals, alternative 
forms of psychotherapy and pharmacotherapy exist that vary widely in effectiveness, 
tolerability, and risk of addiction. This thesis will examine the benefits of a relatively new 
form of adjunctive therapy, transcranial electrical stimulation, and its effects on healthy 
individuals during exposure to fear/anxiety producing stimuli. 
Literature Review 
According to the Diagnostic and Statistical Manual of Mental Disorders V 
anxiety is the apprehensive anticipation of future danger or misfortune accompanied by a 
feeling of worry or distress with a focus on internal or external danger. Often the 
individual’s appraisal of danger and the experience of fear are out of proportion to the 
stimulus and cause interference with the normal brain processes required for 
psychological homeostasis (Gorman, 2004, p. 2).  Researchers and clinicians define 
anxiety as a biological warning system that unites mental and physical reactions to 
potentially dangerous situations (Hoehn-Saric & McLeod, 2000). Regardless of which 
definition one chooses, anxiety exists as a state of negative emotional arousal expressed 
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physiologically in a variety of ways, including increases in facial muscle tension, heart 
rate, blood pressure, respiration, and sweat gland activity (Hoehn-Saric & McLeod, 2000; 
Ragsdale, Mitchell, Cassisi & Bedwell, 2013).   
Most individuals experience anxiety upon presentation of a potentially threatening 
stimulus. In the United States one third of the population will meet the criteria for an 
anxiety disorder at some time in their lives (Biedel et al., 2014). The National Institute of 
Mental Health reports that 18.1% of all U.S. adults have experienced an anxiety related 
disorder in the past 12 months, and of these cases 28% (4.1% of the adult population) are 
severe. Although anxiety disorders are highly treatable, only about one-third of those 
suffering receive treatment (Wang et al., 2005).  In 1999, a study commissioned by the 
Association for Depression and Anxiety Disorders, entitled “The Economic Burden of 
Anxiety Disorders,” and published in the Journal of Clinical Psychiatry concluded that 
anxiety disorders cost the economy $42 billion a year, including $22.84 billion for 
anxiety-related conditions that mimic physical illness. Furthermore, individuals suffering 
an anxiety disorder are three to five times more likely to go to the doctor and six times 
more likely to be hospitalized for psychiatric disorders than those who do not suffer from 
anxiety disorders. 
Currently, DSM-V recognizes 10 distinct syndromes of pathological anxiety 
(American Psychiatric Association, 2013).  Reliable methods have also been developed 
to induce and objectively measure anxiety in animals as well as humans. An examination 
of analogue studies yields 36 commonly accepted procedures for inducing and/or 
measuring anxiety in mice (Kumar, Bhat, and Kumar, 2013). In humans, anxiety induces 
cognitive, emotional and physiological changes that can be assessed using a variety of 
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methods. Physiological changes may be assessed by measuring autonomic arousal as 
indicated by increases in heart rate, blood pressure, sweat gland activity, and respiration 
or by using electromyogram to measure tension in muscles that are sensitive to negative 
emotional valence (Hoehn-Saric & McLeod, 2000). In addition to these physiological 
measurements of anxiety there exists a variety of subjective psychological instruments. 
Therrien and Hunsley (2011) compiled a list of 91 different anxiety instruments, among 
them the State Trait Anxiety Inventory, Hamilton Anxiety Rating Scale, Goldberg 
Anxiety and Depression Scale, General Health Questionnaire, Beck Anxiety Inventory, 
Brief Symptom Inventory, Penn State Worry Questionnaire, and the Symptom Checklist-
90. While these instruments were designed and normed for adult populations between the 
ages of 18 and 60 years, research indicates that they possess clinical utility for older 
adults (age 60-100 years) as well. Children, on the other hand, as their experience of 
psychopathology is different and the nature of the developing brain limits communication 
and understanding of abstract and internal stimuli, require separate instruments such as 
State-Trait Anxiety Inventory for Children, Hospital Fears Rating Scale, Venham Picture 
Test, and Visual Analog Scale (Forester and Park, 2012).  
 Basic scientific research on anxiety and clinical research on patients with anxiety 
disorders have resulted in useful tools for the laboratory assessment of human anxiety. 
Conceptually, emotions are adaptive responses composed of cognitive, experiential, 
behavioral, and physiological reactions to environmental stimuli (Lench, Flores, and 
Bench, 2011). As such, emotions can be measured across a variety of dimensions. One 
simplified way of characterizing emotions is on the basis of valence and arousal. Direct 
measurement of the physiological indicators of valence and arousal in response to 
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experimentally induced emotion enables researchers to measure the magnitude and time 
course of emotional responses in a laboratory setting (Lench et al., 2011). Cognitive and 
physiological similarities, such as effects on memory, threat response, and expressions of 
negative valence and physiological arousal, make a distinction between anxiety and fear 
difficult, often resulting in the use of either term to identify similar constructs (Gorman, 
2004).  
Currently several methods exist to elicit anxiety, including pictures, music, film, 
and verbal emotional priming (Lench et al., 2011). The International Affective Picture 
System (IAPS) is a well-established and widely used source of such (visual) stimuli 
(Lang et al., 1997). It consists of sets of standardized visual stimuli that produce 
predictable emotional reactions with normative ratings for each slide. The IAPS has been 
used in a variety of procedures to assess various participants’ subjective emotional 
experience of external stimuli. Its effectiveness has been confirmed with a wide variety of 
self-assessment procedures (Colden, Bruder, & Manstead, 2008), psychophysiological 
measures (Colden et al., 2008), and imaging techniques such as fMRI (Colden et al., 
2008). Thus, in the current study, we use a combination of self-report measures, such as 
an anxiety inventory and Subjective Units of Distress Scale, and physiological 
measurements, such as facial electromyogram, heart rate, and skin conductance, to assess 
the time and course of emotional responses to repeated exposure to anxiety-inducing 
stimuli from the IAPS database.  
The IAPS set of stimuli was chosen because of its similarity to exposure 
procedures used to treat anxiety. The gold standard for treatment of troublesome anxiety 
and anxiety disorders remains cognitive behavioral therapy. This family of therapies 
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consists of a variety of treatments used in isolation or in combination that include 
cognitive restructuring, exposure, problem solving, applied relaxation, and biofeedback 
(Cuijpers et al., 2014, p. 131). Of all these techniques exposure remains the most 
effective (Harned et al., 2014). This intervention involves systematically confronting 
feared stimuli in a safe and controlled manner so that maladaptive and false beliefs about 
danger are challenged and fear is reduced (McCann et al., 2014). For exposure therapy to 
work, the feared stimuli must be encountered repeatedly until the anxious arousal that 
accompanies the feared stimulus has abated. Several explanations exist as to why this 
technique is so effective. The Emotional Processing perspective holds that repeated 
systematic exposure to a feared stimulus exposes the full fear structure encompassing 
stimulus, response, and meaning elements. As this system is activated, usually indicated 
by increases in anxious arousal, new information incompatible to the client’s fear 
structure is added and integrated (McCann et al., 2014).  
Successful exposure interventions result in a reduction in anxiety after the 
participant experiences several exposures across multiple sessions. When conducting 
these procedures, client subjective perception of anxiety indicates to both the clinician 
and the client the amount of work that is needed. According to Craske et al. (2014), the 
inhibitory learning model of extinction is based on classical conditioning. This model 
posits that the exposure modifies the connection between the conditioned stimulus (CS) 
and the unconditioned stimulus (US). After a successful exposure, the link between CS-
US is altered such that the CS now possesses an additional inhibitory meaning as well as 
the original excitatory meaning.  
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Regardless of perspective, the underlying mechanism remains that the individual 
learns that the fears that accompany the stimulus are irrational. This does not mean that 
the dangers of these stimuli do not exist, but that the individual’s appraisal of the danger 
is inaccurate. In order to teach this lesson, exposure is provided by the clinician either 
covertly (via mental imagery) or in actuality (in vivo) and either gradually (systematic 
desensitization) or all at once (flooding). Despite the effectiveness of exposure as a 
treatment for anxiety, there are drawbacks. It has been argued by Harned et al. (2011, 
2014) that, because exposure involves making the client confront a feared stimulus 
through compulsion, it is insensitive, contraindicated, potentially damaging, and perhaps 
even unethical.  
In addition to the aversive nature of exposure therapies, questions remain 
regarding the generalization of exposure effects beyond the treatment environment. 
Because most exposure therapies are conducted in a safe environment under the 
supervision of a qualified professional, there exists the possibility that conditioning 
effects may be limited to this artificially controlled setting (Craske et al., 2014). Outside 
of the therapeutic context it is possible for the fear to return (i.e., that the extinction 
effects will be specific to the context in which the extinction trials occurred). In other 
words there exists a very real possibility that fears extinguished within the therapeutic 
context will not generalize to the client’s personal environment. In addition as these 
treatments rely on learning, many individuals may not obtain clinically significant 
symptom relief or may experience a delayed return of their anxiety upon termination of 
therapy (Craske et al., 2014).  
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Other individuals experience levels of anxiety that cause them to fail to confront 
the underlying sources of their pathology. Once again Craske et al. (2014) argue that 
these individuals may not be able to effectively engage in extinction learning due to 
deficits that not only limit therapeutic engagement but may also have contributed to the 
original anxiety disorder. In simpler words some clients may just be too anxious to 
undergo exposure treatments. In these cases alternative treatments would include 
psychopharmacological methods, such as selective serotonin reuptake inhibitors (SSRIs) 
and benzodiazepines, which carry their own risks of side effects and misuse (Nutt, 
Ballenger, Sheehan, & Wittchen, 2002),  and other forms of psychotherapy, which may 
cause excessive anxiety and be too costly and time consuming (Nutt et al., 2002).  
Yet for all its potential shortcomings, exposure therapy remains the most effective 
way to treat anxiety disorders. And for the individuals for whom exposure does not quite 
fit, a relatively new device called an Alpha-Stim
®
 exists. This device, when clipped to the 
earlobe, generates a low level electrical current across the cranium and has been shown in 
a variety of studies to reduce depression and anxiety. The use of this device during 
exposure techniques may serve to reduce more quickly the anxiety that accompanies the 
feared stimulus, and the portability of these devices may allow the therapist and client to 
take exposure therapies out of the therapist’s office and into the client’s natural 
environment. This might increase the likelihood that the exposure therapy would 
generalize to environments outside of the therapist’s office.    
Transcranial Electrical Stimulation 
In 1979 the U.S. Food and Drug Administration approved the first transcranial 
electrical stimulation (TCES) devices for the treatment of insomnia, depression, and 
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anxiety. These devices provide noninvasive brain stimulation using pulsed, low 
amplitude electrical current applied to the head via electrodes placed on the ear lobes 
(Barclay & Barclay, 2014; D. Kirsch, personal communication, March 24, 2014). TCES 
was originally approved for the treatment of depression, anxiety, and insomnia (Barclay 
& Barclay, 2014; Kirsch & Nichols, 2013). Other studies have shown TCES to provide 
relief from chronic headaches, low back pain, and fibromyalgia (Lee et al., 2013). It has 
also been used to treat individuals with substance use disorders and withdrawal 
symptoms (Ehlers & Phillips, 2007). Kirsch (2002) identified 126 published studies 
involving 4,541 subjects, the majority of which showed TCES to be effective with few 
side effects. These studies have suggested that TCES is at least as effective as 
biofeedback and relaxation therapies in treating anxiety (Gibson & O’Hair, 1987), and 
superior to placebo in the treatment of insomnia (Bystritsky, Kerwin, & Feusner, 2008; 
Koleoso, Osinowo, & Akhigbe, 2013).   
When the device is clipped to the earlobes, a low-level, 1 mA electrical pulse is 
transmitted across the head at 0.5 hertz, resulting in a resting, or alpha, state (Barclay & 
Barclay, 2014; D. Kirsch, personal communication, March 24, 2014). In this state brain 
activity, as measured by frequency of electroencephalographic tracings, lies between 13 
and 30 Hz across both hemispheres (Kennerly, 2006). These frequencies are produced 
naturally in people who are drowsy or relaxed. Whether produced naturally or artificially, 
this is presumed to reduce stress, stabilize mood, and regulate awareness and perception 
of certain types of pain (Barclay & Barclay, 2014). Thus TCES is presumed to produce 
its effects by inducing changes in brain activity and stimulating the release of various 
neurotransmitters and endorphins (Zaghi, Acar, Hultgren, Paulo, & Fregni, 2009).   
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Research on TCES is relatively new. Because of this, researchers have not yet 
come to agreement regarding the exact mechanisms at work. Zaghi et al. (2009) question 
whether the current directly affects cortical neurons or whether the effect of stimulation is 
mediated by peripheral nerves. Some studies have shown that TCES alters the levels of 
various neurotransmitters in the brain (Ferdjallah et al., 1995; Liss & Liss, 1996; Shealy 
et al., 1998) and changes brainwave activity (Electromedical Products International, Inc., 
2013; Kennerly, 2005). Briones and Rosenthal (1973) documented increases in 24 hour 
urinary free catecholamine in anxiety and asymptomatic patients who were exposed to 
TCES. Shealy et al. (1989) documented observable increases in brain levels of melatonin, 
serotonin, beta-endorphin and norepinephrine. Summarizing earlier research, Zaghi et al. 
(2009) concluded that the evidence was consistent with an association between cranially 
applied alternating current procedures and alterations in neurotransmitter release. 
TCES provides an alternative to traditional pharmacological interventions. First 
line treatment for anxiety disorders includes selective serotonin reuptake inhibitors 
(SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, 
buspirone, and tricyclic antidepressants (TCAs) (Nutt et al., 2002). Compliance with 
treatment remains a problem as medication can sometimes cause adverse effects 
including weight gain, gastrointestinal and sexual difficulties, insomnia, and severe 
headaches (Rivas-Vasquez, 2001). These unintended consequences may often complicate 
compliance as they can be more unpleasant than the condition that they are designed to 
treat. In contrast, most studies on TCES have reported only rare and mild side effects. 
Moustafa et al. (2013) reported that the most common side effects found were headache 
(0.20%) and local skin irritation (0.11%). He also reported other adverse effects including 
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vertigo, dizziness, disorientation, seizures, nausea, and electrical skin burns at the site of 
the electrodes occurring very rarely. Many of these adverse effects can be modified by 
reduction in treatment intensity. An additional benefit is that, unlike pharmacological 
treatments, FDA approved TCES devices cannot be used for overdose or self-harm 
(Moustafa et al., 2013). Finally, the treatment itself is very cost effective. It generally 
consists of teaching the patient to operate the device at home and having their symptoms 
monitored by a licensed professional.  
The Present Study 
TCES has been examined with positive results in a number of studies, with a 
focus particularly on depression, anxiety, insomnia, pain, and substance withdrawal. In 
medical literature, TCES has been examined in clinics for its efficacy in the treatment of 
pain and anxiety for individuals in inpatient, outpatient, psychiatric, dental, and surgical 
settings (Kennerly, 2006). All of these studies have shown decreases in depression, 
anxiety, and pain in comparison to sham treatment groups. What has not been examined 
is the application of a TCES device in the setting of an individual undergoing exposure 
therapy.  
Traditional exposure therapies require that a client experience both controlled 
distress induced by exposure to feared stimuli and a concurrent level of physiological 
arousal (Craske et al., 2004). This process allows the individual to reinterpret the 
relationship between the feared stimulus and physiological arousal. For some exposure 
methods, the individual undergoing treatment is taught relaxation skills to prepare for the 
feared stimulus. Like all skills these relaxation and breathing skills have to be taught and 
practiced before they can bring about any meaningful effect during treatment. And, as 
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previously mentioned, some therapists have ethical concerns about exposing clients to 
feared stimuli. What TCES represents in these cases is an opportunity to control the more 
unpleasant conditions of exposure therapy so that the client can undergo exposure in a 
relaxed/meditative state.  
In light of the research indicating that this treatment is effective for chronic 
depression and anxiety, we test a TCES device called an Alpha-Stim
®
 that is presumed to 
induce an alpha state in the brain. We use a randomized, double-blind placebo-controlled 
study design to evaluate the effect of this device when used as an adjunct to exposure 
treatment. So far studies of this and similar devices have focused on their use as a 
monotherapy for chronic depression, anxiety, pain, and the symptoms that accompany 
substance abuse withdrawal. No research has evaluated these devices for their ability to 
augment current recommended exposure therapies. Because fear and anxiety are so 
similar physiologically, this experiment examines TCES efficacy on reducing anxiety 
induced by exposure to stimuli derived from the IAPS database. It is hypothesized that 
exposure to anxiety provoking stimuli while under the influence of TCES will reduce the 
expected physiological anxiety response in normal volunteers. 
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CHAPTER II 
METHOD
Design 
The Alpha-Stim
®
 device produces its effect in humans by passing a low-level 
electric current across the head by electrodes placed on the earlobes. The current study is 
a randomized, double blind, placebo controlled examination of the efficacy of the Alpha-
Stim
®
 device in reduction of anxiety when the participant is exposed to stimuli designed 
to illicit fear and anxiety. I hypothesize that application of the device during exposure of 
anxiety provoking stimuli will result in a decrease of anxiety.  
Participants 
Seventeen participants were recruited, screened and selected for inclusion in the 
present study. Subjects were drawn from the population of college students currently 
attending Abilene Christian University. Prior to any study-related activities, participants 
were presented with an informed consent document. They were allowed to read the 
document, ask questions about the study procedures, risks, and benefits, and were then 
asked to indicate their willingness to participate by signing the consent document.  
Measurements 
State Trait Anxiety Inventory 
The State Trait Anxiety Inventory (Spielberger, 1968, 1977) is a 40-item scale 
that uses a 4-point Likert scale for each item and can be used to measure both trait 
anxiety (i.e., how a person experiences anxiety over time) and state anxiety (i.e., how a 
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person experiences anxiety in a given moment). The instrument is extensively used in 
both research and practice. Both subscales have been shown to be sensitive to 
experimental manipulation (Bieling et al., 1998). The instrument shows reliability 
coefficients (Cronbach’s alphas) of 0.93for trait subscale and 0.95 for the state subscale 
(Spielberger et al., 1970). 
Subjective Units of Distress (SUDS) 
In order to measure the participants’ subjective feelings of distress, the 
participants were presented with a 100 millimeter line after each exposure, and asked to 
indicate, where on the line they felt their anxiety lay. The lines were marked at 0, 5 
centimeters, and 10 centimeters for reference purposes. 
Equipment 
Physiological samples were collected using the BioPac MP 100 monitoring 
system, running Acknowledge 3.9 acquisition software. Two hundred samples per second 
were recorded from electrocardiogram, electrodermagram and facial electromyography 
channels. Electrocardiogram (ECG) signals were detected using standard snap connected 
Ag/AgCl electrodes placed directly on the skin in a modified lead II configuration, 
negative lead inferior to the right clavicle and positive lead inferior to the terminal rib at 
the left midaxillary line (Lobel, Granic, & Rutger, 2014). R-wave threshold was detected 
automatically and converted to beats per minute. Skin Conductance (EDG) signals were 
detected using BioPac TSD 203 transducers. Two Ag/AgCl 6 mm electrodes, housed in a 
non-polarizable polyurethane housing, were filled with isotonic electrode gel, and 
secured to the fingers of the participant’s non-dominant hand between the interphalangeal 
joints of the first two fingers with velcro straps. Frontalis electromyogram recordings 
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were taken using two 8 mm Ag/AgCl electrodes secured horizontally at the midline of the 
participant’s forehead (over the frontalis muscle, which elevates the eyebrow during 
expressions of negatively valenced emotions (Oberman, Winkleman, & Ramachandran, 
2009). EMG data were reduced and rectified using a root mean square function averaging 
over thirty samples.   
International Affective Picture System (IAPS) 
The International Affective Picture System (Lang, 1997) is a database of pictures 
used for research on emotion and attention. IAPS was developed by the National Institute 
of Mental Health Center for Emotion and Attention at the University of Florida as 
standardized stimuli (Colden et al., 2008). It is comprised of 1,000 color pictures varying 
in emotional valence and arousal with content ranging from  common, daily experiences 
(e.g., household items) to extreme emotional encounters (e.g., mutilated corpses).  
Twenty slides from the set were selected for their ability to reliably evoke fear and/or 
anxiety.  
Procedure 
Participants who met selection criteria were randomly assigned to placebo and 
experimental groups. Experimenters were blind to group membership. The State Trait 
Anxiety Inventory was administered, and one minute of base line physiological 
measurements was recorded. Next, conductive fluid was applied to the electrodes of the 
Alpha-Stim
®
 device and the electrodes were attached to each earlobe. The settings for the 
device (experimental group: 100 mA; control group: off) were set by ACU Psychology 
Clinic staff trained to set up stimulus parameters according to each participant’s 
randomization code. Both groups were then exposed to anxiety-eliciting stimuli derived 
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from the IAPS at a rate of one picture every 60 seconds. The entire exposure lasted 60 
minutes (Electromedical Products International’s, manufacturer of Alpha-Stim®, 
recommended treatment duration). Participants had 3-minute physiological measurements 
taken at the beginning of the exposure, half-way through the exposure and at the end of 
the exposure session. A Subjective Units of Distress Scale (SUDS) was administered 
after each recording. Following completion of the exposure session, the State Trait 
Anxiety Inventory was administered again. A paired-sample student’s t-test was 
performed on measures of state anxiety, and a repeated measures analysis of variance was 
performed to analyze data collected from the subjective units of distress scale and 
physiological measurements. With regards to the physiological measurements, for the 
sake of consistency, data were collected across the procedure; however, only the averages 
of the first and last collection periods were used for statistical analysis to assess change 
across the exposure period.  
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CHAPTER III 
RESULTS
Of the 17 students that met selection criteria, 15 completed the experimental task 
and 2 dropped out. Of these 15 students, 14 were female. The group had a median age of 
22 years with individual ages ranging from 18 to 50 years. The group included two Asian 
students, two African American students and two Hispanic students. The rest were 
Caucasian. Subjects were assigned randomly to treatment and control groups. Pre- and 
post-exposure anxiety levels were measured using the Spielberger State-Trait Anxiety 
Inventory (Form X).  Analysis of paired student’s t-tests revealed no change in state 
anxiety before or after the procedure (t = -1.692, df = 14, p = .126). Means are 
summarized in Table 1.   
Table 1  
State Trait Anxiety Inventory Form X 
 
State Anxiety Confidence Interval 
 
Pretest Posttest Pretest Posttest 
 
Mean (SD) Mean (SD) 95% 95% 
Placebo 31.5 (6.87) 34.62 (9.94) 25.76-37.24 26.31-42.93 
Treatment 34.86 (6.01) 38.92 (9.1) 29.29-40.42 29.90-46.67 
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Figure 1. Mean Subjective Units of Distress (SUDS), taken after the first, second, and 
third exposures. Bars indicate standard error.  
 
A SUDS was administered at three times during the exposure to assess the 
participants’ subjective experience of exposure-related anxiety. A repeated measures 
analysis of variance was conducted to assess the effect of the procedure over time. 
Analysis of SUDS scores (Figure 1) showed a significant effect of time (F(1,13) = 5.831, 
p = .031 η2partial  = .310) indicating that all subjects reported progressively less anxiety 
across the exposure procedure. However SUDS scores showed no significant effects of 
treatment (F(1,13) = .019 p = .891 η2partial  = .001) or time by treatment interaction 
(F(1,13) = .147 p = .147 η2partial  =  .011).  
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Figure 2. Mean SC comparisons (in microSeimens), taken after the first, second, and 
third exposures. Bars indicate standard error.  
 
Physiological measurements of skin conductance, heart rate, and frontalis 
electromyogram were taken at 20-minute intervals during each exposure in order to 
measure the physiological expressions of anxiety induced by the exposure. It was 
hypothesized that these measures of arousal and negative emotional valence would 
decrease throughout the exposure as the participants habituated to the stimuli. It was 
further hypothesized that the treatment group would experience greater decreases in skin 
conductance (EDG), heart rate, and frontalis electromyogram (EMG) than the placebo 
group. Examination of EDG means (Figure 2) yielded no significant effect of treatment 
(F(1,12) = .072 p = .793 η2partial  = .006), time (F(1,12) = .019, p = .894 η
2
partial = .002), or 
time × treatment interaction (F(1,12) = 2.883, p = .115 η2partial = .194).  
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Figure 3. Mean heart rate (in beats per minute), taken after each exposure. Bars indicate 
standard error.  
 
Analysis of heart rate activity (Figure 3) showed a significant effect of treatment 
with active treatment producing lower heart rates (F(1,12) = 120.907 p < .001 η2partial = 
.910), and a trend toward increased heart rate over time (F(1,12) = 3.514, p = .085 η2partial 
= .227), but no treatment x time interaction effects (F(1,12) = .965, p = .345 η2partial = 
.074). Means are summarized in Figure 3. 
 
 
 
 
70
72
74
76
78
80
82
84
1 2 3
B
e
at
s 
p
e
r 
m
in
u
te
 (
+/
- 
st
an
d
ar
d
 e
rr
o
r)
 
Heart Rate 
Control
Treatment
20 
 
 
Figure 4. Mean EDG activity (in microVolts), captured after each exposure. Bars indicate 
standard error.  
 
An analysis of frontalis EMG electrical activity (Figure 4) revealed no main 
effects of treatment (F(1,12) = .228, p = .642 η2partial = .019) or time (F(1,12) = .526, p = 
.482 η2partial = .042), but did show a trend for the treatment × time interaction (F(1,12) = 
3.209, p = .098 η2partial = .211). This trend is shown by the divergent directions of EMG 
change in the experimental and control groups. The control group showed an increase in 
EMG activity over time from 7.5 microvolts to 10.3 microvolts, while the treatment 
group showed a decrease in EMG activity from 8.6 microvolts to 5.7 microvolts.  
0
2
4
6
8
10
12
14
16
Time1 Time 2 Time 3
M
ic
ro
vo
lt
s 
(+
/-
 s
ta
n
d
ar
d
 e
rr
o
r)
 
Frontalis Electromyogram 
Control
Treatment
21 
 
In addition to these subjective and physiological measures, indicators of 
somnolence such as, rapidly blinking eyes, yawning, and head nodding were also 
observed during the experimental manipulation. These behaviors were observed in 4 of 
the 7 participants in the treatment condition and in only 1 of the 8 participants in the 
placebo condition. These treatment effects trended toward significance with a (one-tailed 
Fischer’s exact value of 0.10).
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CHAPTER IV 
DISCUSSION
The purpose of this experiment was to evaluate the ability of a novel transcranial 
electrical stimulation device to facilitate exposure interventions by allowing for control 
over emotional arousal. It was hypothesized that all study subjects would show initial 
increases in physiological arousal and negative emotional valence when exposed to 
anxiety-inducing visual stimuli and that they would habituate to the stimuli as they were 
repeated. I also further hypothesized that transcranial electrical stimulation would 
produce faster habituation and less anxiety.  
The experimental exposure procedure was designed to be analogous to clinical 
exposure procedures used in systematic desensitization. Notable differences in the 
experimental procedure include the use of a nonclinical sample and the use of 
standardized visual stimuli (IAPS) rather than subject-specific anxiety-inducing stimuli 
related to clinical anxiety states. The IAPS stimuli selected for this study were chosen 
because of their ability to induce negative emotional valence, physiological arousal, and 
subjective reports of increased anxiety in healthy adults (Colden et al., 2008). Individual 
pictures depicted a variety of scenes, from interpersonal violence to natural disasters. 
Our study sample was almost uniformly female, a factor that limits general 
application of study findings.  On the other hand, this may have reduced variability in our 
measurements since Barke, Stahl, and Kroner-Herwig (2012) found that women are more 
likely than men to rate stimuli as anxiety-producing.   
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Pretest and posttest anxiety were assessed using the Spielberger State Trait 
Anxiety Inventory Form X (Therrien & Hunsley, 2011). Pretest measures of anxiety 
showed normal levels of anxiety. Comparing pretest and posttest levels of state anxiety 
(Table 1) showed no effects of treatment, time, or their interaction. This demonstrates 
that the exposure procedure was well-tolerated by our subjects and did not induce 
unresolved anxiety. This lack of significant change in state anxiety before and after 
exposure could be due to one of two causes: the exposure did not induce anxiety-related 
distress or subjects habituated to the induced distress. 
  Examination of SUDS demonstrates the effectiveness of our experimental 
manipulation. Analysis of SUDS scores showed that subjects had elevated levels of 
distress early in the exposure period and that these levels decreased as the exposure 
period continued. This is the expected course of anxiety-related distress in an exposure 
session and is consistent with our first hypothesis. The absence of a treatment effect or 
treatment by time interaction shows that the transcranial electrical stimulation did not 
significantly affect subjective levels of distress or the speed at which habituation 
occurred. This might lead one to think that the electrical stimulation had no effect on the 
course of exposure; however, an examination of the physiological data yields a different 
picture. 
Emotions are a complex combination of cognitions, autonomic responses, 
voluntary behaviors, and subjective feelings (Barke et al., 2012).  When people 
experience anxiety, thought processes are focused on the threat stimulus (if known) or are 
used to identify a threat (if not known). Sympathetic nervous system activation leads to 
increased heart rate, increased blood pressure, pupillary dilation, and sweating; skeletal 
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muscles alter tension in preparation to respond to threat or to signal distress to others; and 
subjective experiences of desire to freeze, fight, or flee increase. Many of these anxiety-
related responses can be measured physiologically and are useful in supplementing 
subjective reports of anxiety. In this study, we used three physiological measures to 
assess emotional changes in our subjects. One useful way to view emotions decomposes 
them into a combination of emotional valence (positive or negative) and physiological 
arousal (high or low). Using this model, anxiety is seen as a negative valence, high 
arousal state (Barke et al., 2012). As such, we chose to use galvanic skin conductance as 
a sensitive measure of arousal (Ragsdale et al., 2013), frontalis (the large muscle in the 
forehead) electromyographic activity as a sensitive measure of negative emotional 
valence, and heart rate as a mixed indicator of valence and arousal (Coan & Allen, 2007).   
Normally, when a person is exposed to situations that elicit anxiety, the 
sympathetic nervous system responds by increasing its activity to the degree necessary to 
cope with the situation. This is also true when people with anxiety disorders are exposed 
to stimuli related to their pathology. However, when compared to a healthy population, 
individuals suffering from anxiety disorders frequently show smaller physiological 
responses and diminished physiological flexibility in response to anxiety-provoking 
stimuli not associated with their pathology as indicated by tension measured in the 
frontalis muscle (Hoehn-Saric & McLeod, 2000). In this experiment we were able to 
document small but consistent differences in arousal between placebo and treatment 
groups of healthy college students. We were also able to document divergent valence 
trends between treatment and placebo groups. 
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Overall, the data show that subjects in the treatment group were less 
physiologically aroused, especially early in the course of exposure, than the control 
group. This is seen in the significantly lower heart rate in Figure 3 and the trend in 
increased behaviors indicating somnolence in treatment group subjects. It is surprising 
that the skin conductance data did not reflect the change in arousal level, though the small 
sample sizes significantly limited the power to detect this effect.  
 Interestingly, the data also show a trend-level treatment by time interaction in 
frontalis EMG. This indicates that, while control subjects showed a gradual increase in 
their negative experience of the stimuli, those in the treatment group started out 
experiencing similar levels of negativity that decreased throughout the course of 
exposure. The strength of these findings is, of course, limited by low statistical power. 
Taking the observed physiological responses and the SUDS data together, an 
interesting picture of the exposure session presents itself. While both groups of subjects 
showed increased distress at the beginning of the exposure session and habituated over 
the course of exposure, they had markedly different physiological responses to exposure.  
The control subjects maintained their arousal levels throughout exposure and increased 
their experience of negative valence over time. The subjects receiving active stimulation, 
on the other hand, showed physiological and behavioral evidence of low arousal, 
especially early in the exposure session with some evidence of increased arousal over 
time. This low, but increasing, level of arousal, however, was accompanied by a gradual 
decrease in the experience of negative valence.   
The lower levels of physiological arousal seen in the subjects receiving active 
stimulation are consistent with the previously observed effects of TCES. The fact that this 
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decrease in physiological arousal did not affect the reported SUDS scores during 
exposure suggests that controlling arousal levels with TCES is unlikely to decrease the 
effectiveness of exposure in a therapeutic setting and may even be useful in improving 
the tolerability of exposure procedures for clients who would normally be too anxious. 
Power in this experiment was a problem as we had only 15 subjects (8 placebo, 7 
treatment), which hindered our ability to detect differences between groups. Observed 
power when testing for treatment effects on EDG revealed an η2partial
 
value of .006. This 
value increased only slightly when looking for treatment by time interactions (η2partial = 
.194). As expected, as observed power increased so did significance. An examination of 
the EDG recordings in Figure 2 indicates that participants in the treatment condition had 
a lower skin conductance at first recording that increased to a level equivalent to that of 
the placebo condition at time three, while the placebo condition remained fairly stable.  
We suspect that low observed power in these cases hindered our ability to see significant 
changes more consistent with our hypothesis that the treatment group would show less 
arousal than the placebo group. EMG observed power was insufficient to detect the 
treatment effect at η2partial = .019 but was sufficient enough to detect the treatment by time 
effect at η2partial = .211. 
Blinding in this experiment was also problematic as the TCES could sometimes 
be detected in the EMG recording. At times a distinct repeated pattern would be shown 
during an otherwise flat EMG recording; however, in order to preserve the blinding, no 
recording of this signal was made, nor was any alteration made in this experimental 
procedure, or the statistical analysis as we felt the effects on the collection would not be 
sufficient enough to warrant a change. In addition, one participant reported feeling a 
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slight pulse at the application site of the TCES device. This recollection is made entirely 
from memory, as no other participants reported feeling any similar effects. In order to 
preserve the blinding, this was also not recorded. These problems were encountered 
largely because the experiment team was working with an unfamiliar device. Because 
there was a significant amount of time between recording and analysis and these 
subjective reports were not recorded, we do not believe that there is sufficient reason to 
believe that blinding was significantly affected. However, in future research it would be 
prudent to have the device run by an individual who is not blinded and will not take part 
in the data analysis in order to ensure that the device is operating according to the 
recommended and experimental parameters. This individual would also serve another 
purpose. In addition to operating the device, he/she should also debrief the participant in 
order to insulate the investigator from commentary that may serve to bias the 
experimenter.  
Another limitation of this study is that it uses healthy control subjects rather than 
clinically anxious subjects. This raises the possibility that the effects observed in this 
study may not generalize to the clinical population. As such I can see three possibilities; 
the first is that using transcranial electrical stimulation as an adjunct for exposure 
strategies can have an entirely different effect in a clinical population. Despite the fact 
that this device was developed and tested to treat conditions such as depression, anxiety, 
and insomnia, it is possible that it would not alter arousal levels sufficiently to be 
tolerated in a clinical population. A second possibility is that using the device could yield 
problems similar to that of current exposure therapies, limiting the generalization of 
exposure effects so that the exposure will not translate to conditions when the device is 
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not being worn. Third, the device could lower the perception of anxiety to the point 
where exposure is not effective.  
The goal of exposure is to teach the client to tolerate the experience of negative 
emotions. Our examination of this device indicates that it may be useful in exposure 
procedures by allowing the therapist to control the experience of negative emotion 
making the exposure more tolerable. This experiment documents the ability of the Alpha-
Stim TCES device to alter the emotional arousal and valence experienced during 
exposure to anxiety-provoking stimuli while preserving the expected habituation effects 
seen in the SUDS scores. 
Even though this experiment was not conducted on a clinical population, 
examination of pre and post-test STAI mean scores indicated normal levels of anxiety. If 
a clinical sample of subjects with anxiety disorders showed a similar pattern of decreased 
arousal and negative valence during exposure while experiencing habituation to exposure 
related distress, this experiment would suggest that adjunct TCES would increase a 
participant’s ability to tolerate therapeutic exposure sessions.  
 In summary, this research shows that TCES can decrease levels of arousal and 
negative valence induced by exposure to anxiety provoking stimuli without affecting the 
course of exposure as measured by SUDS.  Because of problems of statistical power and 
external validity, it is important that further research be done on larger samples of clinical 
subjects to further examine the clinical utility of this device. Because of these drawbacks, 
it would seem that this device does warrant further testing in the exposure context, with a 
larger and clinical population.
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APPENDIX 
IAPS STIMULI PRESENTED DURING THE EXPOSURE
The stimuli are listed in the same ascending order. The order is 1112, 1525, 1726, 
2692, 3530, 3550, 5971, 5972, 6190, 6211, 6250, 6300, 6350, 6825, 6940, 9120, 9426, 
9600, 9630. Pictures were assigned an additional number from 1-20 and then assigned a 
slot randomly, by use of a random number generator. No image was used more than once.  
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